Fewer shots for HPV protection? study tests cutting vaccine doses
NCT ID NCT03943875
Summary
This study is testing whether young adults aged 15-26 need two or three doses of the HPV vaccine for protection. Researchers are comparing the standard three-dose schedule against a two-dose schedule with a delayed third dose. They're measuring immune responses in 767 participants to see if two doses provide similar protection against nine HPV types.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Conditions
Explore the condition pages connected to this study.